Literature DB >> 16176996

Antibodies to C reactive protein.

B J Rosenau1, P H Schur.   

Abstract

BACKGROUND: C reactive protein (CRP) is a known indicator of inflammation. Serum CRP is often raised in patients with inflammatory conditions.
OBJECTIVE: To determine whether individuals make antibodies to CRP and whether this might affect serum CRP concentrations.
METHODS: An enzyme linked immunosorbent assay was developed for the detection of antibodies to CRP. Specificity of the reaction was determined by inhibition of the reaction.
RESULTS: Sera from 413 patients were tested and 25 were found to be positive, particularly in patients with rheumatic diseases. Levels of anti-CRP did not correlate with serum CRP levels.
CONCLUSIONS: The presence of low CRP levels may not reflect the presence of antibodies to CRP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176996      PMCID: PMC1798154          DOI: 10.1136/ard.2005.037895

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  18 in total

Review 1.  Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome?

Authors:  M Galli
Journal:  J Autoimmun       Date:  2000-09       Impact factor: 7.094

2.  Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease.

Authors:  A T Erkkilä; O Närvänen; S Lehto; M I Uusitupa; S Ylä-Herttuala
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-01       Impact factor: 8.311

3.  Autoantibodies to C-reactive protein is a common finding in SLE, but not in primary Sjögren's syndrome, rheumatoid arthritis or inflammatory bowel disease.

Authors:  Christopher Sjöwall; Per Eriksson; Sven Almer; Thomas Skogh
Journal:  J Autoimmun       Date:  2002-11       Impact factor: 7.094

4.  Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins.

Authors:  H W Wang; S F Sui
Journal:  Biochem Biophys Res Commun       Date:  2001-10-19       Impact factor: 3.575

Review 5.  C-reactive protein in SLE.

Authors:  M B Pepys; J G Lanham; F C De Beer
Journal:  Clin Rheum Dis       Date:  1982-04

6.  Erythrocyte sedimentation rate. From folklore to facts.

Authors:  S E Bedell; B T Bush
Journal:  Am J Med       Date:  1985-06       Impact factor: 4.965

7.  Antibody to serum amyloid A.

Authors:  Barbara J Rosenau; Peter H Schur
Journal:  J Autoimmun       Date:  2004-09       Impact factor: 7.094

8.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

9.  The internal image of IgG in cross-reactive anti-idiotypic antibodies against human rheumatoid factors.

Authors:  S Fong; T A Gilbertson; D A Carson
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

10.  Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils.

Authors:  Tarek Khreiss; Levente József; Shireen Hossain; John S D Chan; Lawrence A Potempa; János G Filep
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

View more
  11 in total

1.  Could antibodies to C-reactive protein link inflammation and cardiovascular disease in patients with systemic lupus erythematosus?

Authors:  Sean G O'Neill; David A Isenberg; Anisur Rahman
Journal:  Ann Rheum Dis       Date:  2007-08       Impact factor: 19.103

Review 2.  C-reactive protein in rheumatology: biology and genetics.

Authors:  Benjamin Rhodes; Barbara G Fürnrohr; Timothy J Vyse
Journal:  Nat Rev Rheumatol       Date:  2011-04-05       Impact factor: 20.543

3.  Associations of C-reactive protein isoforms with systemic lupus erythematosus phenotypes and disease activity.

Authors:  Jesper Karlsson; Jonas Wetterö; Maria Weiner; Johan Rönnelid; Rafael Fernandez-Botran; Christopher Sjöwall
Journal:  Arthritis Res Ther       Date:  2022-06-11       Impact factor: 5.606

4.  Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus.

Authors:  V Pradhan; A Rajadhyaksha; K Yadav; P Surve; M Patwardhan; N Dhavale; P Pandit; K Ghosh
Journal:  Indian J Nephrol       Date:  2013-11

5.  The relationship between anti-C-reactive protein and disease activity in patients with systemic lupus erythematosus.

Authors:  Chang-Nam Son; Tae-Han Lee; Ji-Hye Bang; Hye-Jin Jeong; Jin-Nyeong Chae; Won-Mok Lee; Ji-Min Kim; Sang-Hyon Kim
Journal:  Korean J Intern Med       Date:  2017-03-31       Impact factor: 2.884

6.  High Prevalence of Autoantibodies Against Monomeric C Reactive Protein (CRP) in Children with PFAPA Syndrome.

Authors:  Barbara Kraszewska-Głomba; Marta Myszka; Magdalena Krajewska; Leszek Szenborn
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

Review 7.  Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?

Authors:  Benoit Brilland; Emeline Vinatier; Jean-François Subra; Pascale Jeannin; Jean-François Augusto; Yves Delneste
Journal:  Front Immunol       Date:  2021-02-16       Impact factor: 7.561

8.  Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis.

Authors:  Christopher Sjöwall; Agneta Zickert; Thomas Skogh; Jonas Wetterö; Iva Gunnarsson
Journal:  Arthritis Res Ther       Date:  2009-12-11       Impact factor: 5.156

9.  Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up.

Authors:  Satu Sinikka Pesickova; Romana Rysava; Martin Lenicek; Libor Vitek; Eliska Potlukova; Zdenka Hruskova; Eva Jancova; Eva Honsova; Jakub Zavada; Marten Trendelenburg; Vladimir Tesar
Journal:  Arthritis Res Ther       Date:  2015-12-24       Impact factor: 5.156

10.  Naturally occurring antibodies against serum amyloid A reduce IL-6 release from peripheral blood mononuclear cells.

Authors:  Tadeja Kuret; Katja Lakota; Polonca Mali; Saša Čučnik; Sonja Praprotnik; Matija Tomšič; Snezna Sodin-Semrl
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.